RGACX
Price
$82.18
Change
+$1.56 (+1.94%)
Updated
Aug 22 closing price
Net Assets
328.96B
RIVBX
Price
$37.67
Change
+$0.64 (+1.73%)
Updated
Aug 22 closing price
Net Assets
206.89M
Interact to see
Advertisement

RGACX vs RIVBX

Header iconRGACX vs RIVBX Comparison
Open Charts RGACX vs RIVBXBanner chart's image
American Funds Growth Fund of Amer R3
Price$82.18
Change+$1.56 (+1.94%)
VolumeN/A
Net Assets328.96B
Riverbridge Growth Institutional
Price$37.67
Change+$0.64 (+1.73%)
VolumeN/A
Net Assets206.89M
RGACX vs RIVBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGACX vs. RIVBX commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGACX is a Buy and RIVBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 329B vs. RIVBX (207M). RGACX pays higher dividends than RIVBX: RGACX (0.07) vs RIVBX (0.00). RGACX was incepted earlier than RIVBX: RGACX (23 years) vs RIVBX (13 years). RIVBX (1.04) is less costly to investors than RGACX (0.94). RGACX is a more actively managed with annual turnover of: 25.00 vs. RIVBX (6.00). RGACX has a lower initial minimum investment than RIVBX: RGACX (250) vs RIVBX (2500). RGACX annual gain was more profitable for investors over the last year : 14.04 vs. RIVBX (12.28). RGACX return over 5 years is better than : 39.56 vs. RIVBX (33.53).
RGACXRIVBXRGACX / RIVBX
Total Expense Ratio0.940.9698%
Annual Report Gross Expense Ratio0.941.0490%
Fund Existence23 years13 years-
Gain YTD14.1557.139198%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets329B207M158,937%
Annual Yield % from dividends0.070.00-
Returns for 1 year14.0412.28114%
Returns for 3 years48.4349.7297%
Returns for 5 years39.5633.53118%
Returns for 10 years104.21174.7660%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EUDA2.600.17
+6.91%
EUDA Health Holdings Limited
YRD6.160.12
+1.99%
Yiren Digital Ltd
OGN9.430.15
+1.62%
Organon & Co
FMS25.600.34
+1.35%
Fresenius Medical Care AG
PMCB0.970.01
+1.04%
PharmaCyte Biotech